How Can Metabolomics Detect Drug Toxicity Early?
How much does our environment influence our health—and what could that mean for precision medicine?
How can researchers identify drug toxicity before it becomes a clinical problem? Metabolomics may offer a way to detect potential safety risks earlier in drug development.
In this episode of ChatGJP, Panome Bio CSO Gary J. Patti explains how metabolomics can reveal unintended effects of drug candidates by tracking changes in biochemical pathways. Although drugs are designed to interact with specific targets, they can also affect other proteins and processes, potentially leading to unwanted effects.
Watch the video to learn how metabolomics could support earlier toxicity detection, improve understanding of drug mechanisms, and help researchers make better-informed decisions about drug candidates before they advance further through development.
Have a Question?
Your privacy is important to us.
We’ll never share your information.